psychological health and a more acute onset of psychotic symptoms and functional impairment in the late teens and early twenties. However, it is yet unclear whether neuroanatomical data among individuals at clinical high risk (CHR) for psychosis can be modeled to detect early versus late neurodevelopmental influences that is predictive of future psychosis onset. Therefore, in this study, we investigated whether the timing of the appearance or course of the deviation from normal brain maturation, as determined using a machine learning algorithm trained on structural MRI data to estimate age, is potentially relevant to the early versus late neurodevelopmental framework among CHR individuals. Methods: A neuroanatomical-based age prediction model was trained using a supervised machine learning technique with T1 MRI scans from 953 typically developing healthy controls (HC) from the Pediatric Imaging, Neurocognition, and Genetics study (PING) study. The trained model was then applied to 109 HCs and 275 CHR, including 39 converters (CHR-C), from the North American Prodrome Longitudinal Study (NAPLS2) and 14 cases of first episode psychosis patients (FE) for external validation and clinical application. Discrepancy between neuroanatomical-based estimated age and chronological age was computed for each individual (i.e., brain age gap) and compared across clinical groups. Results: The PING-derived model for estimating age accurately predicted NAPLS HC subjects' chronological ages, explaining 51% of the variance (P < 0.001) in chronological age, with a mean absolute error of 1.41 years, providing evidence of independent external validation. CHR subjects and FE adolescents showed a significantly greater overestimated gap between model-predicted age and chronological age compared with HC (Ps < 0.01). This effect was significantly moderated by chronological age, with neuroanatomical-based estimated age systematically overestimating CHR cases aged 12-17 years, but not among those aged 18-21 years. In the ROC analysis, brain age gap was a significant predictor of conversion to psychosis with an area under the curve of 0.63 (P < 0.05) among younger adolescents. In addition, increased deviation of brain age gap predicted pattern of stably low functioning over time (P < 0.05) among CHR individuals. In contrast, previously reported evidence of an accelerated reduction in cortical thickness among CHR-C was found to apply only to those cases who were 18 years or older. Discussion: These results are consistent with the view that both early and later neurodevelopmental disturbances contribute to the onset and course of schizophrenia, with the two sets of influences having differing implications for the intercepts and trajectories in structural brain parameters as a function of age. The results also suggest that baseline neuroanatomical measures are likely to be useful in prediction of psychosis especially (or only) among CHR cases who are below 18 years of age at the time of ascertainment. Background: The dysbindin gene (DTNBP1) is located in chromosome 6p22.3, one of the regions of positive linkage for schizophrenia. In particular, dysbindin protein has been found to play a role in the glutatmate neural transmission in the brain. A strong genetic association between DTNBP1 and schizophrenia has been replicated through many recent studies. However, we have not replicated positive association between DTNBP1 and schizophrenia in our Korean sample. Because schizophrenia has been regarded as a disease with a quite heterogeneous origin and evolvement, it is useful to categorize patients with schizophrenia into relatively homogeneous subsets based on clinical characteristics including age at onset (AAO). We investigated the association between DTNBP1 and AAO of schizophrenia.
S185. DTNBP1 IS ASSOCIATED WITH THE AGE AT ONSET OF KOREAN PATIENTS WITH SCHIZOPHRENIA
Background: The dysbindin gene (DTNBP1) is located in chromosome 6p22.3, one of the regions of positive linkage for schizophrenia. In particular, dysbindin protein has been found to play a role in the glutatmate neural transmission in the brain. A strong genetic association between DTNBP1 and schizophrenia has been replicated through many recent studies. However, we have not replicated positive association between DTNBP1 and schizophrenia in our Korean sample. Because schizophrenia has been regarded as a disease with a quite heterogeneous origin and evolvement, it is useful to categorize patients with schizophrenia into relatively homogeneous subsets based on clinical characteristics including age at onset (AAO). We investigated the association between DTNBP1 and AAO of schizophrenia.
Methods:
We assessed age at first occurrence of positive psychotic symptoms of 197 patients with schizophrenia with DSM IV diagnosis, which was reevaluated by Korean version of Diagnostic Interview for Genetic Study. Five SNPs, SNPA, P1763, P1320, P1635 and P1655 of DTNBP1 were genotyped and genetic association analyses were performed using the PLINK program. Results: In SNPA, patients with AT (N=10) showed significant earlier AAO than those with AA (N=187) (p<0.0001). The patients with heterozygote for SNP P1763 (TG, N=40) or P1320 (CT, N=41) also showed significant earlier AAO than those with homozygote (P<0.0001, P<0.0001, respectively). In addition, haplotype of all SNPs (SNPA-P1320-P1635-P1655-P1763) analysis showed significant association with AAO (p=0.000953). Discussion: In conclusion, although we were unable to support an association between DTNBP1 and schizophrenia, DTNBP1 might play a role in disease modifying. However, considering the several limitations of this study, further research involving different polymorphisms in DTNBP1 and various clinical subsets with sufficient numbers will be required to evaluate the contribution of DTNBP1 to schizophrenia. 
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Background: The rs3800779 polymorphism at KCNH2 gene, which encodes for a Voltage-Gated Potassium Channel Subunit, has been associated with the risk for schizophrenia (SZ) and with changes in the expression of a brain isoform with specific electrophysiological characteristics (Huffaker et al., 2009) . It has been hypothesized that the KCNH2 gene variability could be involved in SZ by means of modulating the neuronal excitability. Graph-theory parameters applied to electroencephalographic (EEG) activity are useful to assess functional connectivity in the brain and have shown altered patterns of global connectivity in schizophrenia. We aimed to investigate whether KCNH2 contributes to functional connectivity alterations replicated in SZ patients. Methods: EEG data were acquired during the performance of an odd-ball task in 50 schizophrenia patients and 101 matched healthy controls. The rs3800779 at KCNH2 was genotyped. From the EEG activity, the Small World index (SW, a measure of network efficiency) was calculated as the coefficient between clustering coefficient (CLC, a measure of network segregation) and path length (PL, a measure of network integration). SW was calculated in two temporal windows with respect to the target tone (pre-stimulus and response). Functional SW modulation (SWm) was calculated as the difference in SW between pre-stimulus and response windows. Finally, the association between KCNH2 polymorphism and functional connectivity modulation was assessed. Results: Patients carrying the A allele (AA or AC, n=25) showed smaller SW modulation in comparison with patients with the CC genotype (n=25) (t=-2.84, df=48, p=0.007). Moreover, patients carrying the A allele showed smaller SW modulation than healthy controls with the A allele (n=45) (t=-3.41, df=68, p=0.001) or without the A allele (n=56) (t=-3.87, df=79 p<0.001). There were no significant SW modulation differences between healthy controls carrying or not the A allele. Patients with the AA/AC genotype showed an inverse SW modulation pattern (decreased SW at response) in comparison with patients without the A allele and controls (increased SW at response). Discussion: Our data indicate that, within SZ patients, the A allele is associated with smaller SW modulation and lower SW values at response, which might be interpreted as an altered ability to coordinate the activity
